- Latest news▼
-
20:17, May 2 NBR: low to moderate intensity exercise protects against depression
-
18:28, May 2 Sixth Armenian International Ophthalmological Conference will be held on 17-19 May
-
16:11, May 2 ВJN: High-fat foods may increase the risk of heart attack and stroke at a young age
-
14:16, May 2 Patterns: Neural network created that models outcome of various patient therapy methods
-
12:05, May 2 Armenia joins Council of Europe convention on protection of patients' rights
-
14:27, May 1 Journal of Neuroscience: Sluggishness of the elderly is due to greater use of calories, research finds
-
10:26, May 1 AstraZeneca admits its Covid vaccine can cause thrombosis
-
19:31, April 30 Scientists calculated how much time per day you should be sitting, standing and sleeping
-
17:37, April 30 The Conversation: Keeping bread in the fridge improves its health benefits
-
14:30, April 30 Frontiers in Molecular Biosciences: Researchers use AI to identify 191 new destructive viruses
-
08:38, April 30 The Guardian: First personalized cancer vaccine developed
-
23:55, April 29 Ketodiet improved the condition of patients with schizophrenia and bipolar disorder
-
19:47, April 29 In 64% of COVID-19 survivors, the condition worsens after one year
-
15:41, April 29 ECU: body tilt in patients after stroke was found to be curable
-
13:37, April 29 Blood: blood cancer drugs may be useful in rheumatoid arthritis
All materials
Scientists testing new drug against cancer
Scientists are testing a new revolutionary drug against cancer. Its effectiveness is reportedly in terms of reducing the size of tumors and their weight, Xinhua reported.
According to scientists, one of the main problems with chemotherapy drugs is their uncontrolled activation: they affect not only tumors, but also healthy cells.
The forbiplatin compound studied by scientists can increase the accuracy of chemotherapy. This gives hope for minimizing the damage that healthy cells get during the treatment of cancer, in particular breast and ovarian cancer.
According to studies with rodents, phorbiblatin, activated by red light, leads to a decrease in tumor size by 67% and weight loss by 62% compared with a chemotherapeutic agent (oxaliplatin). Studies have also shown that the main organs of mice were in relatively good condition after treatment with the new drug.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic 1460
- Enzymes that convert different blood groups into first group are discovered 1317
- 3 women diagnosed with HIV for first time after getting ‘beauty injections’ in US 1163
- In 64% of COVID-19 survivors, the condition worsens after one year 874
- 362 cases of measles recorded in Armenia so far in 2024 845
- Ketodiet improved the condition of patients with schizophrenia and bipolar disorder 839
- ECU: body tilt in patients after stroke was found to be curable 799
- Blood: blood cancer drugs may be useful in rheumatoid arthritis 768
- The Guardian: First personalized cancer vaccine developed 714
- Scientists calculated how much time per day you should be sitting, standing and sleeping 702
- The Conversation: Keeping bread in the fridge improves its health benefits 683
- Frontiers in Molecular Biosciences: Researchers use AI to identify 191 new destructive viruses 674
- AstraZeneca admits its Covid vaccine can cause thrombosis 626
- Journal of Neuroscience: Sluggishness of the elderly is due to greater use of calories, research finds 521
- Armenia joins Council of Europe convention on protection of patients' rights 289
- Find us on Facebook
- Poll